Month: May 2014

New CDC Guidelines: People at Risk for HIV Should Consider Truvada PrEP

Healthcare providers should advise people at “substantial risk” for HIV infection about pre-exposure prophylaxis (PrEP) using tenofovir/emtricitabine, or Truvada, according to new guidelines issued by the U.S. Centers for Disease Control and Prevention (CDC). This includes HIV negative people in an ongoing sexual relationship with HIV positive partners, gay or bisexual men who have had sex …

New CDC Guidelines: People at Risk for HIV Should Consider Truvada PrEP Read More »

PMMA-microspheres for the treatment of HIV-associated buttock lipodystrophy.

Soft tissue augmentation with PMMA-microspheres for the treatment of HIV-associated buttock lipodystrophy. Authors Serra MS, et al.  Journal Int J STD AIDS. 2014 May 22. pii: 0956462414536878. [Epub ahead of print] Affiliation Abstract BACKGROUND: Progression of lipodystrophy syndrome is a big challenge in HIV treatment. Nowadays, fat loss at the lower part of buttocks has become another …

PMMA-microspheres for the treatment of HIV-associated buttock lipodystrophy. Read More »

Scroll to Top